AIDS Epidemic

Vaginal Gel Helps Women Cut AIDS Risk

As the world hopes for an HIV vaccine following recent positive developments, a new study in South Africa shows that a vaginal gel made using Gilead Sciences' AIDS drug Viread cut HIV infections in women by as much as 50%.